Beam Therapeutics Inc. (BEAM) has a market capitalization of $3.09B and trades at $30.30. The 52-week range is 13.525-36.44.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -37.4, Earnings Per Share (EPS) of $-0.81, annual revenue of $139.74M.
The stock has a beta of 2.19, operates in the Healthcare sector.
